ROLE OF THE RESEARCH COORDINATOR
|
|
|
- Garey Eaton
- 10 years ago
- Views:
Transcription
1 Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Data Collection and Data Management Best Practices 21CFR Part 11 1
2 Objectives Definitions used in Clinical Trial Data Collection Lifecycle of the Data Management Plan Source Document Tips and Tricks Electronic Documentation and Requirements of 21 CFR Part 11 2
3 Definitions Key to Research Documentation 1. Source documents are original records and certified copies of original records of clinical findings and observations, or other activities in a clinical trial necessary for the reconstruction and evaluation of the trial. section 1.51 ICH E6 GCP 2. Case Report Forms (CRFs) A printed, optical, or electronic document designed to record all of the protocol required information to be reported to the sponsor for each trial subject (section 1.11 ICH E6 GCP) to capture essential source data about the subject for analysis to answer the hypothesis of a study. 3
4 Source Examples Original paper clinical visit note signed by a clinical professional (i.e. nurse, physician) at UCSF or in the community Electronic Medical Record (EMR) notes or reports scanned into EMR from outside medical offices Test results printed from an institutional EMR Pathology reports or procedures results Specific form created by CRC for the study to record a mandatory process required by the protocol (i.e. PK sample shipment log, patient drug diary) TIP: All Source must have a signature, original or electronic, by the person creating the source 4
5 Case Report Form (CRF) Examples Standardized and formatted document used in the same way for all subjects to transfer source data points into a database CRFs are provided by the study sponsor or created specifically for a P.I. initiated trial Best Practice: Designed or reviewed and signed off by the statistician who will be responsible for analysis Can be paper (but seen less today), excel spreadsheets or electronic CTMS (Best Practice) Abstraction from source documents is the only method for 5
6 Definitions Key to the Data Management Plan 1. Data Management Is the responsibility of the research staff and a host of other IT professionals related to collecting, entering, securing, and preserving data as a valuable, and reproducible resource for the outcome of the study. 2. Data Integrity Includes the development of policies and ethical practices for consistent procedures that properly manage the full data lifecycle needs for the outcome of a clinical trial. The principal investigator is the person responsible for data integrity, but must rely on a team of research professionals in IT and the research coordinators to uphold the policies. 6
7 What does Data Integrity Look Like? 1. A relentless a8en9on to detail and an impeccable ability to Follow GCP guidelines, and Carry out the protocol precisely as wri8en. 2. A passion for Accuracy, Completeness, and Timeliness of data entry and data correc9ons. 7
8 Who is Key in the Source to Data Lifecycle to Achieve Data Integrity? It involves many different research members! Clinicians, Nurses and Clinical Research Coordinators (Site) Clinical Research Associates or CRA Monitors (Industry) Data Safety Committee (DSC) monitors Data Offices (Industry) Database Managers Biostatisticians (Site or Industry) Nurses, Doctors who manage safety offices for drug manufacturers (Industry) * The Investigator is the custodian of the Data Chain at the site level 8
9 Data Management Plan Lifecycle Collecting Entering Reviewing Cleaning Coding (MedDRA, COSTART, ICD9 are common coding systems) Auditing Locking Final product is a database containing data mirroring the source document ready for statistical analysis and publication or presentation. 9
10 Data Management Plan Best Practice; Let the Protocol Begin! 1. Protocol is approved CRFs are created based on the protocol Source Data is collected and entered and reviewed for accuracy in the CRF electronic system 4. Statistical Analysis data is pulled for analysis 5. Principal Investigator reviews, signs off and publishes 10
11 Source Documentation Important Differences to Responsibilities A Research Coordinator creates, collects and organizes Clinical Trial Documenta9on that is not medical or involving care of the subject. Medical Staff and Nursing Staff documents protocol required care or assessment of the subject s outcomes, adverse events, and compliance to study procedures. 11
12 Source Documentation Tips and Tricks When you need the subject to create the source If the subject creates a source form, have them sign it since it becomes original documentation. Create a study calendar for the subject so that appointments and procedures occur on schedule. Monitor subject s study compliance and report and record protocol deviations from the data time points in the protocol. If subject diaries are created, find ways to ensure they are complete and collected on time at each visit. 12
13 Source Documentation Tips and Tricks Obtain medical reports; create forms clinicians and nurses to use to help them comply with 9me points or assessments required per protocol. Create and maintain source documents; may use a copy of documents in a research chart for each subject. Meet and interview subject at each visit using forms that follow the protocol. Process and ship study specimens on 9me; complete logs and note devia9ons or missed samples. Safe shipping cer.fica.on for FAA regula.ons 49 CFR
14 Source Documentation Tips and Tricks Examples of must have documentation Informed consent given and ques9ons answered Eligibility criteria met for enrollment Discrepancy of study medica9on and returns of study medica9on Severity and causality/a8ribu9on of adverse events Devia9ons and viola9ons of protocol *Failure to capture this documenta9on will show up in audit reports against the site 14
15 Source Documentation If it is not documented it did not happen! ALCOA =Attributable-Legible-Contemporaneous- Original-Accurate No white out if paper Line through incorrect data, must be legible Date and initial changes and additions by appropriate research staff person Electronic Medical Records present security, and other legal challenges; know UCSF regulations *Always follow research documentation guidelines! 15
16 The Study Coordinator, Will it Ever Really Be PAPERLESS? Careful what you wish for! 16
17 If its Electronic Source, Now What? Electronic Security is a very big problem!! Never use portable disks, flash drives to transport or store patient source data!!! HIPAA violations come with serious fines HIPAA violations require lots of time to notify subjects Correcting electronic clinical information must be done in the electronic system and resigned by clinician on study team. It should not be done on a paper printout! Never sign or enter passwords for someone else Printouts if used for research patient files, must have a date/time stamp and show who printed the source document to make it verifiable as a copy Access to EMR by external staff from CRO or FDA requires an approval from Health Information Management 17
18 If its Electronic Source, Now What? Regulation 21 CFR 11(August 2003) provides criteria for acceptance by FDA of electronic records, electronic signatures FDA Guidance for Industry Computerized Systems Used in Clinical Investigations (May 2007) provides current thinking on records in electronic form that are used to create, modify, maintain, archive, retrieve, or transmit clinical data required; and ensuring confidence in the reliability, quality and integrity of electronic source data and source documentation. 18
19 If its Electronic Source, Now What? FDA recommenda9ons on Internal Security Safeguards: Limited Access (individual account with log in access and unauthorized access per log- in a8empts), Audit Trails (track all changes made to informa9on entered in electronic system that documents ac9vi9es related to the conduct of the trial), Date/Time Stamps (includes year, month, day, hour and minute) with limited access to changing this within the system. FDA recommends that computer educa9on, training, and experience be documented. 19
20 Data Entry into Case Report Forms or CRFs CRF is designed for entering data to the database consistently Delegated task from the PI to the research coordinator, but the PI remains responsible for the integrity of data. Abstracted from the source document such as pharmacy records, clinical office notes Can be either paper or electronic and follows the same electronic security rules as the source documentation Designed by Sponsor or Cooperative group or study coordinator may design forms for investigator initiated trials. Changing or correcting entries follow the same rules as source: changes must show a date and identify of person, must be legible, never obliterate prior entry Data Entry must be accurate and complete! 20
21 Examples of Electronic Databases used in Clinical Trials Must be compliant with 21CFR Part 11 FDA Electronic Records and Electronic signatures CTMS is a clinical trial management system. Creates, collects, stores, analyzes, allows monitoring and auditing for large amounts of data! It is a customizable software system used by the biotechnology and pharmaceutical industries to manage the large amounts of data involved with the operation of a clinical trial. Has CRFs and security built in with rules to maintain data integrity, security, and storage. Examples include:. UCSF: OnCore - possesses the ability to manage most data items and UCSF: iris - Allows users to electronically submit research applications and other related forms to their institute's review board(s) Industry sponsors - Inform, Phase Forward, Medidata Rave 21
22 Case Report Form (CRF) Tips and Tricks Only collect and enter data required for analysis Too much data = *noise* which interferes with analysis; use of a statistician as part of the data management plan will manage the data! Code entries whenever possible to minimize text which cannot be analyzed in statistical programs. Do not collect the same variable more than once so errors can be minimized. Double data entry is a process used to catch errors quickly because usually two people entering data do not make the exact same mistake. Clean data is the best data! 22
23 Case Report Form Tips and Tricks All forms include should use a header to identify protocol and form name since the subject code rather than subject PHI should be used. Personal identifiers removed using IDs: Patient ID, and Site ID Check with investigator before choosing a data dictionary term when the symptom written in the source is not available in the database. ASK before entry! Before you enter any data that you are unsure about.ask your investigator and ASK your monitor 23
24 Takeaways Data integrity is everyone s responsibility but the Principal Investigator is the custodian at the site level. The role of the Clinical Research Coordinator is the assure source documentation and data abstraction and entry are being done at the protocol specified timepoints. Electronic data, whether source in the electronic medical record or the pure data in the case report form, holds additional security issues. 24
Managing & Validating Research Data
Research Management Standard Operating Procedure ISOP-H02 VERSION / REVISION: 2.0 EFFECTIVE DATE: 01 03 12 REVIEW DATE: 01 03 14 AUTHOR(S): CONTROLLER(S): APPROVED BY: Information Officer; NBT Clinical
ROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Study Start-up
Data Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International
Data Management and Good Clinical Practice Patrick Murphy,, Family Health International 1 What is GCP? Good Clinical Practice is an international ethical and scientific quality standard for designing,
Good Documentation Practices
Good Documentation Practices Clinical Research Operations & Regulatory Support Ann Glasse, RN, BSN, MBA Director, Regulatory Support Author: Johanna Stamates, RN, MA, CCRC, CHRC Objectives Recognize the
Data Management Unit Research Institute for Health Sciences, Chiang Mai University
Data Management Unit Research Institute for Health Sciences, Chiang Mai University Clinical Data Management is the process of handling data from clinical trials. The inherent goal of any clinical data
Nova Southeastern University Standard Operating Procedure for GCP. Title: Electronic Source Documents for Clinical Research Study Version # 1
Nova Southeastern University Standard Operating Procedure for GCP Title: Electronic Source Documents for Clinical Research Study Version # 1 SOP Number: OCR-RDM-006 Effective Date: August 2013 Page 1 of
Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA
Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA This presentation is the property of DynPort Vaccine Company LLC, a CSC company, and
Electronic Medical Records and Source Data for Research: What s the Difference?
Electronic Medical Records and Source Data for Research: What s the Difference? Tammy Anderson, CCRC, CCRA, CRCP Director, Clinical Trials Office Virginia Commonwealth University Research Coordinator 4
Update on Monitoring & Electronic Medical Records at UCSF
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Update on Monitoring & Electronic Medical Records January 10, 2012 at UCSF Danusia Filipowski, MD Director,
Data Management & Case Report Form Development in Clinical Trials. Introduction to the Principles and Practice of Clinical Research.
Data Management & Case Report Form Development in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 3, 2015 Marge Good, RN, MPH, OCN Nurse Consultant Division of
What is Clinical Data Management
What is Clinical Data Management Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems to support collection,
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled.
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems to support collection, cleaning and management of subject
How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program
How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program Presenter: Jan Holladay Pierre, MPH Quality Principal Leader DynPort Vaccine Company LLC, A CSC Company This presentation
Guidance for Industry Computerized Systems Used in Clinical Investigations
Guidance for Industry Computerized Systems Used in Clinical Investigations U.S. Department of Health and Human Services Food and Drug Administration (FDA) Office of the Commissioner (OC) May 2007 Guidance
CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE]
CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CONTRACT RESEARCH ORGANIZATION SPONSOR [NAME] [ADDRESS] 1 TABLE OF CONTENTS 1. Purpose 3 2. References 3 3. Study Roles and Responsibilities
Remote Monitoring of Clinical Trials and EMRs
Remote Monitoring of Clinical Trials and EMRs Sandra SAM Sather, MS, BSN, CCRA, CCRC Vice-President Clinical Pathways LLC [email protected] Lindsey Spangler, J.D. Associate Director,
DHHS/NIH/OD/OIR/OHSRP 1/2/2015
DHHS/NIH/OD/OIR/OHSRP 1/2/2015 The audience for this course is Principal Investigators (PIs), investigators and Research Coordinators (RCs) serving on the study team of human clinical studies and trials.
Guidance for Industry
Guidance for Industry Electronic Source Data in Clinical Investigations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for
ACDM GUIDELINES TO FACILITATE PRODUCTION OF A DATA HANDLING PROTOCOL
ACDM GUIDELINES TO FACILITATE PRODUCTION OF A DATA HANDLING PROTOCOL BACKGROUND The need was identified by the Electronic Data Transfer Special Interest Group (SIG) for each company or organisation to
Clinical Data Management (Process and practical guide) Dr Nguyen Thi My Huong WHO/RHR/RCP/SIS
Clinical Data Management (Process and practical guide) Dr Nguyen Thi My Huong WHO/RHR/RCP/SIS Training Course in Sexual and Reproductive Health Research Geneva 2012 OUTLINE Clinical Data Management CDM
Comprehensive Study Documents List (Biomedical Studies)
Comprehensive Study Documents List (Biomedical Studies) Investigators conducting human subjects research must maintain study documents in adherence to federal and state regulations, USC policies, and good
Clinical Data Management (Process and practical guide) Nguyen Thi My Huong, MD. PhD WHO/RHR/SIS
Clinical Data Management (Process and practical guide) Nguyen Thi My Huong, MD. PhD WHO/RHR/SIS Training Course in Sexual and Reproductive Health Research Geneva 2013 OUTLINE Overview of Clinical Data
Development of Case Report Forms
Development of Case Report Forms Introduction to the Principles and Practice of Clinical Research February 12, 2013 Diane St. Germain, RN, MS Nurse Consultant Division of Cancer Prevention National Cancer
No. 706. Page 1 of 5. Issue Date 4/21/2014
Subject: ROUTINE MONITORING VISITS Standard Operating Procedure Prepared By: Beaumont Research Coordinating Center, Research Institute PURPOSE Prior Issue Date 8/15/2011 No. 706 Issue Date 4/21/2014 Page
DATA MANAGEMENT IN CLINICAL TRIALS: GUIDELINES FOR RESEARCHERS
Reference Number: UHB 139 Version Number: 2 Date of Next Review: 14 Apr 2018 Previous Trust/LHB Reference Number: N/A DATA MANAGEMENT IN CLINICAL TRIALS: GUIDELINES FOR RESEARCHERS Introduction and Aim
Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: [email protected]
SAMPLE CRA CV Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: [email protected] Education: Masters of Science, Healthcare Administration, Capital City University,
The Monitoring Visit. Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis
The Monitoring Visit Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis Disclosure The information herein is not intended to
Reflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical trials
09 June 2010 EMA/INS/GCP/454280/2010 GCP Inspectors Working Group (GCP IWG) Reflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical
The Importance of Good Clinical Data Management and Statistical Programming Practices to Reproducible Research
The Importance of Good Clinical Data Management and Statistical Programming Practices to Reproducible Research Eileen C King, PhD Research Associate Professor, Biostatistics Acting Director, Data Management
Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity
Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity Michelle Quaye Regulatory Manager, Advanced Therapy Trials University College London Overview The Principles of Good
Investigational Drugs: Investigational Drugs and Biologics
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
Adverse Events in Clinical Trials: Definitions and Documentation
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators Adverse Events in Clinical Trials: Definitions
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
Managing Data in Clinical Research. Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group
Managing Data in Clinical Research Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Clinical data management (CDM) is a multidisciplinary
This unit will provide the structure needed to achieve successful supervision and oversight of the study. We will explain the importance of an
Music No audio Please review information shown to understand the general course navigation and available resources. Resources, such as the audio script, example forms, and website links, can be accessed
Guidance for Industry COMPUTERIZED SYSTEMS USED IN CLINICAL TRIALS
Guidance for Industry COMPUTERIZED SYSTEMS USED IN CLINICAL TRIALS U.S. Department of Health and Human Services Food and Drug Administration Center for Biologic Evaluation and Research (CBER) Center for
The Study Site Master File and Essential Documents
The Study Site Master File and Essential Documents Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 002 Version number: 1 Effective date: 01 June 2010
QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH
QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH Martin Valania, Executive Director, Corporate QA and Compliance Introduction Pharmaceutical companies recognize the benefits of carefully managing
What is necessary to provide good clinical data for a clinical trial?
What is necessary to provide good clinical data for a clinical trial? Alain Barrois, Assistant Clinical Trials Operations Manager #EBMT2015 www.ebmt.org Is this a (typical) clinical trial? 2 Agenda Introduction
Signature Requirements for the etmf
Wingspan Technology Signature Requirements for the etmf A Regulatory and Technological Assessment Kathie Clark Director, Product Management Wingspan Technology 1 November 2012 Signature Requirements for
Guidance for Industry
Guidance for Industry Electronic Source Data in Clinical Investigations DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft
INTERIM SITE MONITORING PROCEDURE
INTERIM SITE MONITORING PROCEDURE 1. PURPOSE The purpose of this SOP is to describe the interim monitoring procedures conducted at Institution, according to GCP and other applicable local regulations.
CONTROLLED DOCUMENT- DO NOT COPY STANDARD OPERATING PROCEDURE. STH Investigator
Research Department STANDARD OPERATING PROCEDURE STH Investigator Archiving of Essential Documentation Generated During Clinical Research SOP Number A127 Version Number V1.3 Effective Date Author Zoe Whiteley
IMP management at site. Dmitry Semenyuta
IMP management at site Dmitry Semenyuta TOP 5 FDA inspections finding 1999-2009 Center of Drug Evaluation and Research (CDER) Failure to follow the protocol Failure to keep adequate and accurate records
Health Care Job Information Sheet #20. Clinical Research
Health Care Job Information Sheet #20 Clinical Research A. Background B. Occupations 1) Clinical Research Associate (Study Monitor) 2) Clinical Research Coordinator 3) Other positions in the field C. Labour
Supplement to the Guidance for Electronic Data Capture in Clinical Trials
Supplement to the Guidance for Electronic Data Capture in Clinical Trials January 10, 2012 Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Note: The original language of this
The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations
The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations Maria Luisa Paoloni OPBG Clinical & Research Services Monitoring and Responsible of monitoring:
RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING
RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING July 2006 TABLE OF CONTENTS Page 1. Introduction 2 2. Scope 2 3. Documents to be archived 2 4. Quality of essential documents 10 5.
Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
STANDARD OPERATING PROCEDURES FOR GOOD CLINICAL PRACTICE
STANDARD OPERATING PROCEDURES FOR GOOD CLINICAL PRACTICE UNC OB/GYN (V.1) 9.1.2014 Page i TABLE OF CONTENTS INTRODUCTION. iii ABBREVIATIONS iv GLOSSARY v LISTING OF ATTACHMENTS.... xi I. 1.0 GENERAL ADMINISTRATION
Needs, Providing Solutions
Identifying Needs, Providing Solutions 1 I n d u s t r y The growth of medical research and the countless innovations coming from the pharmaceutical, biotechnology and medical device industry, has improved
Guidance for electronic trial data capturing of clinical trials
Guidance for electronic trial data capturing of clinical trials 1 st November, 2007 Japan Pharmaceutical Manufacturing Association pg. 1 Table of Contents 1. Background... 3 2. Purpose... 3 3. Scope...
Guideline for Developing Randomization Procedures RPG-03
The Clinical Research Center Research Practice Manual Guideline for Developing Randomization Procedures RPG-03 Purpose Guideline The purpose of this Guideline is to outline the Clinical Research Center
Standard Operating Procedures
Standard Operating Procedures 5.5.1 Electronic Data Handling History Version Date Author Reason 1.1 18 th July 2007 B Fazekas New procedure 1.2 18 th August B Fazekas Changes ratified by MAB 2007 1.3 16
STANDARD OPERATING PROCEDURE FOR DATA RETENTION
STANDARD OPERATING PROCEDURE FOR DATA RETENTION SOP Number: GCP DM 505.02 Version Number & Date: 2 nd Version; 25 Apr 2013 Superseded Version Number & Date (if applicable): 1 st Version; 17 June 2010 Effective
CNE Disclosures. To change this title, go to Notes Master
CNE Disclosures Successful Completion: Participants must complete an evaluation form to receive a certificate of completion Contact Hours: 1 contact hour is available to those who meet the successful completion
UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE
UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES University of Leicester (UoL)
The Importance of Following the PROTOCOL in Clinical Trials
The Importance of Following the PROTOCOL in Clinical Trials Presentation Objectives: Upon completion of this presentation, participants will be able to: Describe the following terms: Protocol, Protocol
Clinical database/ecrf validation: effective processes and procedures
TITOLO SLIDE Testo Slide Testo Slide Testo Slide Clinical database/ecrf validation: effective processes and procedures IV BIAS ANNUAL CONGRESS Padova September, 26 th 2012 PQE WORKSHOP: What's new in Computerized
ICH CRA Certification Guide March 2009
ICH CRA Certification Guide March 2009 ICH CRA CERTIFICATION GUIDE... 1 GENERAL INFORMATION... 2 BENEFITS OF CERTIFICATION... 2 INDUSTRY RECOGNITION... 2 ABOUT THE EXAM... 2 CRA DEFINITION... 2 REQUIREMENTS
12.0 Investigator Responsibilities
v. 5.13.13 12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement,
Data Management in Clinical Trials
Data Management in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 19, 2013 Diane St. Germain, RN, MS Nurse Consultant Division of Cancer Prevention National Cancer
Clinical Data Management. Sponsored by Center for Cancer Research National Cancer Institute
Clinical Data Management Sponsored by Center for Cancer Research National Cancer Institute Introduction Clinical data management (CDM) consists of various activities involving the handling of data or information
Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute
Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute Understand the protocol completely Recognize institutional polices
Data Manager s Role in Data Quality
Data Manager s Role in Data Quality and KPI for Data Management Process May 17 th, 2011 Beijing, China Joyce Lai MSD (Shanghai) Pharmaceutical Consultancy Co, Ltd. Agenda Why is the Data Manager So Important
CoSign for 21CFR Part 11 Compliance
CoSign for 21CFR Part 11 Compliance 2 Electronic Signatures at Company XYZ Company XYZ operates in a regulated environment and is subject to compliance with numerous US government regulations governed
Clinical Investigator Training Course
Clinical Investigator Training Course Investigator Responsibilities in Biomedical Research Covered by FDA Regulations Lisa Zimmerman Objectives Discuss Clinical Investigator Obligations according to FDA
GCP INSPECTORS WORKING GROUP <DRAFT> REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS
European Medicines Agency London, 17 October 2007 Doc. Ref. EMEA/505620/2007 GCP INSPECTORS WORKING GROUP REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS
Objectives. The Paper Tells the Story
Notes to File: An Auditor s Perspective Lorrie D. Divers, CCRP, RQAP-GCP Executive Director, Global Quality Assurance & Compliance ACM Medical Laboratory / ACM Global Central Laboratory Clinical Translation
Record Keeping. Guide to the Standard for Professional Practice. 2013 College of Physiotherapists of Ontario
Record Keeping Guide to the Standard for Professional Practice 2013 College of Physiotherapists of Ontario March 7, 2013 Record Keeping Records tell a patient s story. The record should document for the
Guideline for Developing Randomization Procedures RPG-03
The Clinical Research Center Research Practice Manual Guideline for Developing Randomization Procedures RPG-03 Purpose Guideline The purpose of this Guideline is to outline the Clinical Research Center
Use of Electronic Health Record Data in Clinical Investigations
Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
REGULATIONS COMPLIANCE ASSESSMENT
ALIX is free software: you can redistribute it and/or modify it under the terms of the GNU General Public License as published by the Free Software Foundation. REGULATIONS COMPLIANCE ASSESSMENT BUSINESS
Duke Ethics & Compliance Office Update 2014
Duke Ethics & Compliance Office Update 2014 Research Wednesday January 22, 2014 Margaret Groves, JD, CRA CCRP Director, CTQA Objectives Discuss the recent merger of the School of Medicine Compliance Office
GOOD CLINICAL PRACTICE: CONSOLIDATED GUIDELINE
ICH E6 GCP: Consolidated Guideline: Investigator 1/7 Institutional Review Board Services ICH HARMONIZED TRIPARTITE GUIDELINE E6: GOOD CLINICAL PRACTICE: CONSOLIDATED GUIDELINE 4. INVESTIGATOR 4.1 Investigator's
2. For all clinical trials, the coverage analysis will also be audited to ensure compliance with the Medicare National Coverage Determination.
COMPLIANCE PROGRAM POLICY: Clinical Research Billing Audit Policy Effective Date: August 1, 2014 Last Updated: Page 1 of 8 I. POLICY All UC Irvine Health departments engaged in clinical research may be
Documentation of the Informed Consent Process. USC Office for the Protection of Research Subjects (OPRS)
Documentation of the Informed Consent Process USC Office for the Protection of Research Subjects (OPRS) Session Overview Highlights: Purpose of Informed Consent (IC) IC Process and Documentation Witness
Infoset builds software and services to advantage business operations and improve patient s life
Infoset builds software and services to advantage business operations and improve patient s life Clinical Data Management ecrf & EDC Patient Support Programs Medication Adherence Mobile e-health Big Data
This interpretation of the revised Annex
Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2011, Vol. 31 No. 4 www.ispe.org Copyright ISPE 2011 The ISPE GAMP Community of Practice (COP) provides its interpretation
R&D Administration Manager. Research and Development. Research and Development
Document Title: Document Number: Patient Recruitment SOP031 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D Administration Manager,
Archiving of Research Documentation
Suspension, Termination & Completion Standard Operating Procedure VERSION / REVISION: 2.0 EFFECTIVE DATE: 28 05 12 REVIEW DATE: 28 05 14 AUTHOR(S): CONTROLLER: APPROVED BY: Clinical Trials Manager; Recruitment
Centralized vs Onsite Monitoring:
Centralized vs Onsite Monitoring: A Sponsor s Balancing Act Applying a Risk-based Approach Introduction Since the August 2011 release of the draft guidance document by FDA on a risk-based approach to monitoring
Subject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure
703 1 of 11 POLICY The Beaumont Research Coordinating Center (BRCC) will provide advice to clinical trial investigators on protocol development, content and format. Upon request, the BRCC will review a
Version history Version number Version date Effective date 01 dd-mon-yyyy dd-mon-yyyy 02 dd-mon-yyyy dd-mon-yyyy 03 (current) dd-mon-yyyy dd-mon-yyyy
Trial name: HOVON xxx yyy Sponsor: HOVON Version history Version number Version date Effective date 01 dd-mon-yyyy dd-mon-yyyy 02 dd-mon-yyyy dd-mon-yyyy 03 (current) dd-mon-yyyy dd-mon-yyyy QRMP authors
RD SOP17 Research data management and security
RD SOP17 Research data management and security Version Number: V2 Name of originator/author: Dr Andy Mee, R&I Manager Name of responsible committee: R&I Committee Name of executive lead: Medical Director
BUILDING QUALITY INTO CLINICAL TRIALS AN FDA PERSPECTIVE
BUILDING QUALITY INTO CLINICAL TRIALS AN FDA PERSPECTIVE Jean Toth-Allen, Ph.D. Biophysicist Office of Good Clinical Practice Office of the Commissioner May 14, 2012 1 Overview I. Background why we are
Self-Assessment of eresearch Compliance with 21 CFR Part 11, Electronic Record; Electronic Signatures
Self-Assessment of eresearch Compliance with 21 CFR Part 11, Electronic Record; Electronic Signatures Subpart A General Provisions Sec. 11.1 Scope. (a) The regulations in this part set forth the criteria
Full Compliance Contents
Full Compliance for and EU Annex 11 With the regulation support of Contents 1. Introduction 2 2. The regulations 2 3. FDA 3 Subpart B Electronic records 3 Subpart C Electronic Signatures 9 4. EU GMP Annex
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry By http://www.clinicalresearchassociate cra.com/studyguide/ A clinical research associate (CRA) is a
POLICY ISSUES IN E-COMMERCE APPLICATIONS: ELECTRONIC RECORD AND SIGNATURE COMPLIANCE FDA 21 CFR 11 ALPHATRUST PRONTO ENTERPRISE PLATFORM
W H I T E P A P E R POLICY ISSUES IN E-COMMERCE APPLICATIONS: ELECTRONIC RECORD AND SIGNATURE COMPLIANCE FDA 21 CFR 11 ALPHATRUST PRONTO ENTERPRISE PLATFORM This white paper is written for senior executives
Objectives. Monitoring & Auditing of Clinical Trials. Overview. Pre-study Qualification Visit. Industry-sponsored Trials
Objectives Monitoring & Auditing of Clinical Trials Sponsored by Center for Cancer Research National Cancer Institute Guidelines suggest that following the good clinical research practice of monitoring/auditing
HIPAA Privacy & Security Training for Clinicians
HIPAA Privacy & Security Training for Clinicians Agenda This training will cover the following information: Overview of Privacy Rule and Security Rules Using and disclosing Protected Health Information
Essential Documents for the Conduct of a Clinical Trial. Debra Dykhuis Associate Director RSO
Essential Documents for the Conduct of a Clinical Trial Debra Dykhuis Associate Director RSO Introduction Rationale for choosing this topic AHC movement toward setting GCP (Good Clinical Practice) guidelines
FDA Regulation of Electronic Source Data in Clinical Investigations
FDA Regulation of Electronic Source Data in Clinical Investigations Q1 Productions Second Annual Innovations in Clinical Data Management Conference, Arlington, VA Mahnu Davar Presented on Oct. 28, 2014
